Real-world data of zanubrutinib treatment for patients with previously treated Waldenstrom Macroglobulinemia

被引：0
|
作者：
Jang, Seo Yoon [1 ]
Kwon, Soyean [1 ]
Byun, Ja Min [1 ]
Koh, Youngil [1 ]
Hong, Junshik [1 ]
Yoon, Sung-Soo [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-429
引用
收藏
页码：S277 / S277
页数：1
相关论文
共 50 条
  • [31] Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenstrom macroglobulinemia
    Castillo, Jorge J.
    Gustine, Joshua N.
    Meid, Kirsten
    Dubeau, Toni E.
    Xu, Lian
    Yang, Guang
    Hunter, Zachary R.
    Advani, Ranjana
    Palomba, Lia
    Treon, Steven P.
    HAEMATOLOGICA, 2018, 103 (10) : E466 - E468
  • [32] Real World Experience on the Use of Ibrutinib Monotherapy in Waldenstrom Macroglobulinemia
    Ogunbiyi, Olabisi
    Arulogun, Suzanne O.
    Patel, Aisha
    Rismani, Ali
    Kyriakou, Charalampia
    D'Sa, Shirley
    BLOOD, 2021, 138
  • [33] Real-World Clinical Outcomes in Patients With Myelofibrosis (MF) Previously Treated With Ruxolitinib (RUX)
    Jain, Tania
    Katzen, Harvey
    Zeng, Jia
    Nguyen, Hiep
    Aton, Lindsay
    Qureshi, Parisa
    Fares, Marielle
    Shih, Yu-Hsuan
    Tang, Derek
    Vergara, Sara
    DeGutis, Irene S.
    Gerds, Aaron T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S379 - S379
  • [34] Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting
    Fonseca, Eduardo
    Iglesias, Raquel
    Paradela, Sabela
    Fernandez-Torres, Rosa M.
    Elberdin, Laida
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (03) : 217 - 222
  • [35] Zanubrutinib for the treatment of patients with Waldenstrom macroglobulinemia: 3 years of follow-up (vol 136, pg 2027, 2020)
    Trotman, J.
    Opat, S.
    Gottlieb, D.
    BLOOD, 2021, 137 (08) : 1131 - 1131
  • [36] Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
    Santoni, Matteo
    Heng, Daniel Y.
    Bracarda, Sergio
    Procopio, Giuseppe
    Milella, Michele
    Porta, Camillo
    Matrana, Marc R.
    Carteni, Giacomo
    Crabb, Simon J.
    De Giorgi, Ugo
    Basso, Umberto
    Masini, Cristina
    Calabro, Fabio
    Vitale, Maria Giuseppa
    Santini, Daniele
    Massari, Francesco
    Galli, Luca
    Fornarini, Giuseppe
    Ricotta, Riccardo
    Buti, Sebastiano
    Zucali, Paolo
    Caffo, Orazio
    Morelli, Franco
    Carrozza, Francesco
    Martignetti, Angelo
    Gelibter, Alain
    Iacovelli, Roberto
    Mosca, Alessandra
    Atzori, Francesco
    Vau, Nuno
    Incorvaia, Lorena
    Ortega, Cinzia
    Scarpelli, Marina
    Lopez-Beltran, Antonio
    Cheng, Liang
    Paolucci, Vittorio
    Graham, Jeffrey
    Pierce, Erin
    Scagliarini, Sarah
    Sepe, Pierangela
    Verzoni, Elena
    Merler, Sara
    Rizzo, Mimma
    Sorgentoni, Giulia
    Conti, Alessandro
    Piva, Francesco
    Cimadamore, Alessia
    Montironi, Rodolfo
    Battelli, Nicola
    CANCERS, 2020, 12 (01)
  • [37] Bortezomib as a Treatment Option in Patients With Waldenstrom Macroglobulinemia
    Dimopoulos, Meletios A.
    Chen, Christine
    Kastritis, Efstathios
    Gavriatopoulou, Maria
    Treon, Steven P.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (02): : 110 - 117
  • [38] Extended rituximab therapy for previously untreated patients with Waldenstrom's macroglobulinemia
    Dimopoulos, MA
    Zervas, C
    Zomas, A
    Hamilos, G
    Gika, D
    Efstathiou, E
    Panayiotidis, P
    Vervessou, E
    Anagnostopoulos, N
    Christakis, J
    CLINICAL LYMPHOMA, 2002, 3 (03): : 163 - 166
  • [39] ZANUBRUTINIB WAS ACTIVE IN HEAVILY TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OR WALDENSTROM MACROGLOBULINEMIA. EARLY OBSERVATIONS FROM THE ITALIAN NAMED PATIENTS PROGRAM
    Visentin, A.
    Tani, M.
    Ferrarini, I.
    Vitale, C.
    Rigamonti, C.
    Weber, D.
    Mauro, F. R.
    Tedeschi, A.
    Visco, C.
    Coscia, M.
    Trentin, L.
    HAEMATOLOGICA, 2021, 106 (10) : 161 - 161
  • [40] Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab
    Levy-Mendelovich, Sarina
    Brutman-Barazani, Tami
    Budnik, Ivan
    Avishai, Einat
    Barg, Assaf A.
    Levy, Tamara
    Misgav, Mudi
    Livnat, Tami
    Kenet, Gili
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
12345